Skip to main content
Top
Published in: Rheumatology International 9/2009

01-06-2009 | Original Article

Mycobacterium tuberculosis infection precipitates SLE in patients from endemic areas

Authors: Kanjaksha Ghosh, Manisha Patwardhan, Vandana Pradhan

Published in: Rheumatology International | Issue 9/2009

Login to get access

Abstract

In a cohort of 70 systemic lupus erythematosus (SLE) patients diagnosed over 2 years period, 14 patients were found to have confirmed antecedent tuberculosis (20.0%) which was 40 times higher (p < 0.001, 95%CI 36.2–48.6) than the prevalence of tuberculosis in the local population. Demonstration of anti-histone antibodies in similar proportion of SLE patients with and without antecedent anti-TB treatment and similar proportion of renal involvement (36 vs. 40%) between anti-TB drug exposed and non-exposed patients ruled out the drugs to be causative factors in precipitating SLE in these patients with antecedent history of tuberculosis. A cohort of 30 confirmed pulmonary tuberculosis patients were also studied in parallel to demonstrate high incidence of autoantibodies in these patients but no SLE. This study suggests a role of prior tuberculosis in precipitating SLE in genetically predisposed patients.
Literature
1.
go back to reference Erdozain JG, Ruiz-Irastroza G, Ebubride MV, Mantinez-Berrriot Xoa A (2006) Aguirrec, high risk of tuberculosis in systemic lupus erythematosus? Lupus 15:232–235. doi:10.1191/0961203306lu2289xx Erdozain JG, Ruiz-Irastroza G, Ebubride MV, Mantinez-Berrriot Xoa A (2006) Aguirrec, high risk of tuberculosis in systemic lupus erythematosus? Lupus 15:232–235. doi:10.​1191/​0961203306lu2289​xx
2.
go back to reference Sayarlioglu M, Inanc M, Kamali S, Cefle A, Karamen O, Gul A et al (2004) Tuberculosis in Turkish patients with systemic lupus erythematosus: increased frequency of extrapulmonary localisation. Lupus 13:274–278. doi:10.1191/0961203303lu529xx PubMedCrossRef Sayarlioglu M, Inanc M, Kamali S, Cefle A, Karamen O, Gul A et al (2004) Tuberculosis in Turkish patients with systemic lupus erythematosus: increased frequency of extrapulmonary localisation. Lupus 13:274–278. doi:10.​1191/​0961203303lu529x​x PubMedCrossRef
3.
go back to reference Balakrishnan C, Hangat G, Mittal G, Joshi VR (1998) Tuberculosis in patients with systemic lupus erythematosus. J Assoc Phys Ind 46:682–683 Balakrishnan C, Hangat G, Mittal G, Joshi VR (1998) Tuberculosis in patients with systemic lupus erythematosus. J Assoc Phys Ind 46:682–683
4.
go back to reference Yun JE, Lee SW, Kim TH, Jun JB, Jung S, Bae SC, Kim TY, Yoo DH (2002) The incidence and clinical characteristics of tuberculosis infection among systemic lupus erythematosus and Rheumatoid arthritis patients in Korea. Clin Exp Rheumatol 20:127–132PubMed Yun JE, Lee SW, Kim TH, Jun JB, Jung S, Bae SC, Kim TY, Yoo DH (2002) The incidence and clinical characteristics of tuberculosis infection among systemic lupus erythematosus and Rheumatoid arthritis patients in Korea. Clin Exp Rheumatol 20:127–132PubMed
5.
go back to reference Lamm DL, Blumenstein BA, Crowford ED, Montie JE, Scardino P, Grossman HB et al (1991) A randomized trial of intravesical doxorubicin and immunotherapy with Bacille Calmette-Guerin for transitional cell carcinoma of the bladder. N Engl J Med 352:1205–1209CrossRef Lamm DL, Blumenstein BA, Crowford ED, Montie JE, Scardino P, Grossman HB et al (1991) A randomized trial of intravesical doxorubicin and immunotherapy with Bacille Calmette-Guerin for transitional cell carcinoma of the bladder. N Engl J Med 352:1205–1209CrossRef
6.
go back to reference Krone B, Kolmel KF, Henz BM, Wange JM (2005) Protection against melanoma by vaccination of Bacille Calmette guerin (BCG) and/or vaccinia: an epidemiology based hypothesis on the nature of melanoma risk factor and its immunological control. Eur J Cancer 41:104–117. doi:10.1016/j.ejca.2004.08.010 PubMedCrossRef Krone B, Kolmel KF, Henz BM, Wange JM (2005) Protection against melanoma by vaccination of Bacille Calmette guerin (BCG) and/or vaccinia: an epidemiology based hypothesis on the nature of melanoma risk factor and its immunological control. Eur J Cancer 41:104–117. doi:10.​1016/​j.​ejca.​2004.​08.​010 PubMedCrossRef
7.
go back to reference Burling F, Ng J, Thein H, Ly J, Marshall MR, Gow P (2007) Ethnic, clinical and immunological factors in systemic lupus erythematosus and the development of lupus nephritis: results from a multiethnic New Zealand cohort. Lupus 16:830–837. doi:10.1177/0961203307080225 PubMedCrossRef Burling F, Ng J, Thein H, Ly J, Marshall MR, Gow P (2007) Ethnic, clinical and immunological factors in systemic lupus erythematosus and the development of lupus nephritis: results from a multiethnic New Zealand cohort. Lupus 16:830–837. doi:10.​1177/​0961203307080225​ PubMedCrossRef
9.
go back to reference Holoshitz J, Hatitisk A, Cohen IR (1984) Arthritis induced in rats by cloned T lymphocytes responsive to mycobacteria but not to collagen type II. J Clin Invest 73:211–215. doi:10.1172/JCI111193 PubMedCrossRef Holoshitz J, Hatitisk A, Cohen IR (1984) Arthritis induced in rats by cloned T lymphocytes responsive to mycobacteria but not to collagen type II. J Clin Invest 73:211–215. doi:10.​1172/​JCI111193 PubMedCrossRef
10.
go back to reference Van Eden U, Holoshitz J, Nevo Z, Frenkel A, Klugman A, Cohen IR (1985) Arthritis induced by a T lymphocyte clone that responds to mycobacterium tuberculosis and to cartilage proteoglycans. Proc Natl Acad Sci USA 82:5117–5120. doi:10.1073/pnas.82.15.5117 PubMedCrossRef Van Eden U, Holoshitz J, Nevo Z, Frenkel A, Klugman A, Cohen IR (1985) Arthritis induced by a T lymphocyte clone that responds to mycobacterium tuberculosis and to cartilage proteoglycans. Proc Natl Acad Sci USA 82:5117–5120. doi:10.​1073/​pnas.​82.​15.​5117 PubMedCrossRef
12.
go back to reference Pradhan VD, Badakere SS, Ghosh K, Pawar A (2004) Spectrum of anti-neutrophil cytoplasmic antibodies in patients with pulmonart tuberculosis overlaps with that of Wegener’s Granulomatous. Int J Med Sci 58:283–288 Pradhan VD, Badakere SS, Ghosh K, Pawar A (2004) Spectrum of anti-neutrophil cytoplasmic antibodies in patients with pulmonart tuberculosis overlaps with that of Wegener’s Granulomatous. Int J Med Sci 58:283–288
14.
go back to reference Shoenfield Y, Schwatz RS (1984) Immunologic and genetic factors in autoimmune diseases. N Engl J Med 311:1019–1029 Shoenfield Y, Schwatz RS (1984) Immunologic and genetic factors in autoimmune diseases. N Engl J Med 311:1019–1029
15.
go back to reference Shoenfoeld Y, Vilner Y, Coates ARM, Ranch J, Lavie G, Shaul D et al (1986) Monoclonal antituberculosis antibodies react with DNA and monoclonal anti-DNA autoantibodies react with Mycobacterium tuberculosis. Clin Exp Immunol 66:255–261 Shoenfoeld Y, Vilner Y, Coates ARM, Ranch J, Lavie G, Shaul D et al (1986) Monoclonal antituberculosis antibodies react with DNA and monoclonal anti-DNA autoantibodies react with Mycobacterium tuberculosis. Clin Exp Immunol 66:255–261
16.
go back to reference Purice S, Mitu S, Popescu T, Guran M, Vintila M, Suta G (1982) The relationship between systemic lupus erythematosus and tuberculosis. Med Interne 20:191–196PubMed Purice S, Mitu S, Popescu T, Guran M, Vintila M, Suta G (1982) The relationship between systemic lupus erythematosus and tuberculosis. Med Interne 20:191–196PubMed
17.
go back to reference Correa PA, Gomez LM, Cadena J, Anaya JM (2005) Autoimmunity and tuberculosis. Opposite association with TNF polymorphism. J Rheumatol 32:219–225PubMed Correa PA, Gomez LM, Cadena J, Anaya JM (2005) Autoimmunity and tuberculosis. Opposite association with TNF polymorphism. J Rheumatol 32:219–225PubMed
18.
go back to reference Sanger C, Busche A, Bentien G, Spallek R, Jonas F, Bohle A et al (2004) Immunodominant Pst S1 antigen of Mycobacterium tuberculosis is a potent biological response modifier for the treatment of bladder cancer. BMC Cancer 4:86. doi:10.1186/1471-2407-4-86 PubMedCrossRef Sanger C, Busche A, Bentien G, Spallek R, Jonas F, Bohle A et al (2004) Immunodominant Pst S1 antigen of Mycobacterium tuberculosis is a potent biological response modifier for the treatment of bladder cancer. BMC Cancer 4:86. doi:10.​1186/​1471-2407-4-86 PubMedCrossRef
Metadata
Title
Mycobacterium tuberculosis infection precipitates SLE in patients from endemic areas
Authors
Kanjaksha Ghosh
Manisha Patwardhan
Vandana Pradhan
Publication date
01-06-2009
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 9/2009
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-009-0903-x

Other articles of this Issue 9/2009

Rheumatology International 9/2009 Go to the issue